Expression and Relevance of TRPS-1: A New GATA Transcription Factor in Breast Cancer

Hormones and Cancer

Volumn 2, Issue 2, 2011, Pages 132-143

  Chen, Jie Qing ^a,b   Bao, Yi ^a,b   Litton, Jennifer ^a   Xiao, Li ^b   Zhang, Hua Zhong ^b   Warneke, Carla L ^b   Wu, Yun ^b   Shen, Xiaoyun ^c   Wu, Sheng ^a   Katz, Ruth L ^b   Sahin, Aysegul ^b   Bondy, Melissa ^b   Murray, James L ^a   Radvanyi, Laszlo ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; GATA 3; Immunohistochemistry; Transcription factor; Trichorhinophalangeal syndrome type 1; TRPS 1

Indexed keywords

AMPHIREGULIN; ARYLAMINE ACETYLTRANSFERASE; CADHERIN; CASEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 5; TRANSCRIPTION FACTOR GATA 6; TRICHORHINOPHALANGEAL SYNDROME 1 PROTEIN; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

ARTICLE; BREAST CANCER; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL FATE; CORRELATION ANALYSIS; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; BREAST NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; GATA TRANSCRIPTION FACTORS; HUMANS; MICE; PROGNOSIS; RATS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952626758     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-011-0067-5     Document Type: Article

References (67)

1. Keen JC, Davidson NE (2003) The biology of breast carcinoma. Cancer 97: 825-833.
2. Van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
3. Dubart A, Romeo PH, Vainchenker W, Dumenil D (1996) Constitutive expression of GATA-1 interferes with the cell-cycle regulation. Blood 87: 3711-3721.
4. Freedman OC, Verma S, Clemons MJ (2005) Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution? Cancer Treat Rev 31: 1-17.
5. Gordon NH, Silverman P, Lasheen W, Meinert J, Siminoff LA (2007) Thirty-year follow-up of chemo/hormonal therapy in node-positive breast cancer. Breast Cancer Res Treat 102: 301-312.
6. Tlsty TD (2007) Luminal cells GATA have it. Nat Cell Biol 9: 135-136.
7. Chen JQ, Litton J, Xiao L, Zhang HZ, Warneke CL, Wu Y, Shen X, Wu S, Sahin A, Katz R et al (2010) Quantitative immunohistochemical analysis and prognostic significance of TRPS-1, a new GATA transcription factor family member, in breast cancer. Horm Cancer 1: 21-33.
8. Radvanyi L, Singh-Sandhu D, Gallichan S, Lovitt C, Pedyczak A, Mallo G, Gish K, Kwok K, Hanna W, Zubovits J et al (2005) The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Proc Natl Acad Sci USA 102: 11005-11010.
9. Fantauzzo KA, Bazzi H, Jahoda CA, Christiano AM (2008) Dynamic expression of the zinc-finger transcription factor Trps1 during hair follicle morphogenesis and cycling. Gene Expr Patterns 8: 51-57.
10. Gai Z, Zhou G, Itoh S, Morimoto Y, Tanishima H, Hatamura I, Uetani K, Ito M, Muragaki Y (2009) Trps1 functions downstream of Bmp7 in kidney development. J Am Soc Nephrol 20: 2403-2411.
11. Itoh S, Kanno S, Gai Z, Suemoto H, Kawakatsu M, Tanishima H, Morimoto Y, Nishioka K, Hatamura I, Yoshida M et al (2008) Trps1 plays a pivotal role downstream of Gdf5 signaling in promoting chondrogenesis and apoptosis of ATDC5 cells. Genes Cells 13: 355-363.
12. Suemoto H, Muragaki Y, Nishioka K, Sato M, Ooshima A, Itoh S, Hatamura I, Ozaki M, Braun A, Gustafsson E et al (2007) Trps1 regulates proliferation and apoptosis of chondrocytes through Stat3 signaling. Dev Biol 312: 572-581.
13. Wuelling M, Kaiser FJ, Buelens LA, Braunholz D, Shivdasani RA, Depping R, Vortkamp A (2009) Trps1, a regulator of chondrocyte proliferation and differentiation, interacts with the activator form of Gli3. Dev Biol 328: 40-53.
14. Viger RS, Taniguchi H, Robert NM, Tremblay JJ (2004) Role of the GATA family of transcription factors in andrology. J Androl 25: 441-452.
15. Molkentin JD (2000) The zinc finger-containing transcription factors GATA-4, -5, and -6 ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 275: 38949-38952.
16. Crispino JD (2005) GATA1 in normal and malignant hematopoiesis. Semin Cell Dev Biol 16: 137-147.
17. Patient RK, McGhee JD (2002) The GATA family (vertebrates and invertebrates). Curr Opin Genet Dev 12: 416-422.
18. Charpentier AH, Bednarek AK, Daniel RL, Hawkins KA, Laflin KJ, Gaddis S, MacLeod MC, Aldaz CM (2000) Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res 60: 5977-5983.
19. Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X, Langerod A, Karesen R, Oh DS, Dressler LG et al (2004) Mutation of GATA3 in human breast tumors. Oncogene 23: 7669-7678.
20. Guo M, Akiyama Y, House MG, Hooker CM, Heath E, Gabrielson E, Yang SC, Han Y, Baylin SB, Herman JG et al (2004) Hypermethylation of the GATA genes in lung cancer. Clin Cancer Res 10: 7917-7924.
21. Cullen ME, Patient RK (1997) GATA-1 DNA binding activity is down-regulated in late S phase in erythroid cells. J Biol Chem 272: 2464-2469.
22. Ho IC, Pai SY (2007) GATA-3-not just for Th2 cells anymore. Cell Mol Immunol 4: 15-29.
23. Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z (2006) GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127: 1041-1055.
24. Hoch RV, Thompson DA, Baker RJ, Weigel RJ (1999) GATA-3 is expressed in association with estrogen receptor in breast cancer. Int J Cancer 84: 122-128.
25. Wolf I, Bose S, Williamson EA, Miller CW, Karlan BY, Koeffler HP (2007) FOXA1: growth inhibitor and a favorable prognostic factor in human breast cancer. Int J Cancer 120: 1013-1022.
26. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J et al (2007) Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9: 201-209.
27. Kouros-Mehr H, Kim JW, Bechis SK, Werb Z (2008) GATA-3 and the regulation of the mammary luminal cell fate. Curr Opin Cell Biol 20: 164-170.
28. Williamson EA, Wolf I, O'Kelly J, Bose S, Tanosaki S, Koeffler HP (2006) BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1). Oncogene 25: 1391-1399.
29. Yan W, Cao QJ, Arenas RB, Bentley B, Shao R (2010) GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. J Biol Chem 285: 14042-14051.
30. Eeckhoute J, Keeton EK, Lupien M, Krum SA, Carroll JS, Brown M (2007) Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res 67: 6477-6483.
31. Knight WA 3rd, Osborne CK, Yochmowitz MG, McGuire WL (1980) Steroid hormone receptors in the management of human breast cancer. Ann Clin Res 12: 202-207.
32. Bertucci F, Houlgatte R, Benziane A, Granjeaud S, Adelaide J, Tagett R, Loriod B, Jacquemier J, Viens P, Jordan B et al (2000) Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet 9: 2981-2991.
33. Jenssen TK, Kuo WP, Stokke T, Hovig E (2002) Associations between gene expressions in breast cancer and patient survival. Hum Genet 111: 411-420.
34. Mehra R, Varambally S, Ding L, Shen R, Sabel MS, Ghosh D, Chinnaiyan AM, Kleer CG (2005) Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res 65: 11259-11264.
35. Oh DS, Troester MA, Usary J, Hu Z, He X, Fan C, Wu J, Carey LA, Perou CM (2006) Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. J Clin Oncol 24: 1656-1664.
36. Voduc D, Cheang M, Nielsen T (2008) GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value. Cancer Epidemiol Biomark Prev 17: 365-373.
37. Albergaria A, Paredes J, Sousa B, Milanezi F, Carneiro V, Bastos J, Costa S, Vieira D, Lopes N, Lam EW et al (2009) Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours. Breast Cancer Res 11: R40.
38. Ciocca V, Daskalakis C, Ciocca RM, Ruiz-Orrico A, Palazzo JP (2009) The significance of GATA3 expression in breast cancer: a 10-year follow-up study. Hum Pathol 40: 489-495.
39. Thorat MA, Marchio C, Morimiya A, Savage K, Nakshatri H, Reis-Filho JS, Badve S (2008) Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis. J Clin Pathol 61: 327-332.
40. Chang GTG, Steenbeek M, Schippers E, Blok LJ, van Weerden WM, van Alewijk DCJG, Eussen BHJ, van Steenbrugge GJ, Brinkmann AO (2000) Characterization of a zinc-finger protein and its association with apoptosis in prostate cancer cells. J Natl Cancer Inst 92: 1414-1421.
41. Li JJ, Li SA (2003) Causation and prevention of solely estrogen-induced oncogenesis: similarities to human ductal breast cancer. Adv Exp Med Biol 532: 195-207.
42. Chang GT, van den Bemd GJ, Jhamai M, Brinkmann AO (2002) Structure and function of GC79/TRPS1, a novel androgen-repressible apoptosis gene. Apoptosis 7: 13-21.
43. Graham K, de las Morenas A, Tripathi A, King C, Kavanah M, Mendez J, Stone M, Slama J, Miller M, Antoine G et al (2010) Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile. Br J Cancer 102: 1284-1293.
44. Graham K, Ge X, de Las Morenas A, Tripathi A, Rosenberg CL (2011) Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epithelium. Clin Cancer Res 17: 236-246.
45. Momeni P, Glockner G, Schmidt O, von Holtum D, Albrecht B, Gillessen-Kaesbach G, Hennekam R, Meinecke P, Zabel B, Rosenthal A et al (2000) Mutations in a new gene, encoding a zinc-finger protein, cause tricho-rhino-phalangeal syndrome type I. Nat Genet 24: 71-74.
46. Malik TH, Shoichet SA, Latham P, Kroll TG, Peters LL, Shivdasani RA (2001) Transcriptional repression and developmental functions of the atypical vertebrate GATA protein TRPS1. EMBO J 20: 1715-1725.
47. Malik TH, Von Stechow D, Bronson RT, Shivdasani RA (2002) Deletion of the GATA domain of TRPS1 causes an absence of facial hair and provides new insights into the bone disorder in inherited tricho-rhino-phalangeal syndromes. Mol Cell Biol 22: 8592-8600.
48. Li JJ, Weroha SJ, Lingle WL, Papa D, Salisbury JL, Li SA (2004) Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats. Proc Natl Acad Sci USA 101: 18123-18128.
49. van Agthoven T, van Agthoven TL, Dekker A, Foekens JA, Dorssers LC (1994) Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations. Mol Endocrinol 8: 1474-1483.
50. Li JJ, Papa D, Davis MF, Weroha SJ, Aldaz CM, El-Bayoumy K, Ballenger J, Tawfik O, Li SA (2002) Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer. Mol Carcinog 33: 56-65.
51. Li SA, Weroha SJ, Tawfik O, Li JJ (2002) Prevention of solely estrogen-induced mammary tumors in female ACI rats by tamoxifen: evidence for estrogen receptor mediation. J Endocrinol 175: 297-305.
52. Turan VK, Sanchez RI, Li JJ, Li SA, Reuhl KR, Thomas PE, Conney AH, Gallo MA, Kauffman FC, Mesia-Vela S (2004) The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17beta-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16alpha-hydroxyestradiol, and 4-hydroxyestrone. J Endocrinol 183: 91-99.
53. Weroha SJ, Li SA, Tawfik O, Li JJ (2006) Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats. Carcinogenesis 27: 491-498.
54. Al-Dosari MS, Alkuraya FS (2010) Trichorhinophalangeal syndrome: report of a novel familial TRPS1 mutation. Clin Dysmorphol 19: 98-100.
55. Chen LH, Ning CC, Chao SC (2010) Mutations in TRPS1 gene in trichorhinophalangeal syndrome type I in Asian patients. Br J Dermatol 163: 416-419.
56. Hatamura I, Kanauchi Y, Takahara M, Fujiwara M, Muragaki Y, Ooshima A, Ogino T (2001) A nonsense mutation in TRPS1 in a Japanese family with tricho-rhino-phalangeal syndrome type I. Clin Genet 59: 366-367.
57. Ludecke HJ, Schaper J, Meinecke P, Momeni P, Gross S, von Holtum D, Hirche H, Abramowicz MJ, Albrecht B, Apacik C et al (2001) Genotypic and phenotypic spectrum in tricho-rhino-phalangeal syndrome types I and III. Am J Hum Genet 68: 81-91.
58. Piccione M, Niceta M, Antona V, Di Fiore A, Cariola F, Gentile M, Corsello G (2009) Identification of two new mutations in TRPS 1 gene leading to the tricho-rhino-phalangeal syndrome type I and III. Am J Med Genet A 149A: 1837-1841.
59. Piscopo DM, Johansen EB, Derynck R (2009) Identification of the GATA factor TRPS1 as a repressor of the osteocalcin promoter. J Biol Chem 284: 31690-31703.
60. Napierala D, Sam K, Morello R, Zheng Q, Munivez E, Shivdasani RA, Lee B (2008) Uncoupling of chondrocyte differentiation and perichondrial mineralization underlies the skeletal dysplasia in tricho-rhino-phalangeal syndrome. Hum Mol Genet 17: 2244-2254.
61. Kaiser FJ, Tavassoli K, van den Bemd GJ, Chang GT, Horsthemke B, Moroy T, Ludecke HJ (2003) Nuclear interaction of the dynein light chain LC8a with the TRPS1 transcription factor suppresses the transcriptional repression activity of TRPS1. Hum Mol Genet 12: 1349-1358.
62. Kanno S, Gui T, Itoh S, Gai Z, Sun Y, Oikawa K, Yoshida M, Muragaki Y (2011) Aberrant expression of the P2 promoter-specific transcript Runx1 in epiphyseal cartilage of Trps1-null mice. Exp Mol Pathol 90: 143-148.
63. van den Bemd GJ, Jhamai M, Brinkmann AO, Chang GT (2003) The atypical GATA protein TRPS1 represses androgen-induced prostate-specific antigen expression in LNCaP prostate cancer cells. Biochem Biophys Res Commun 312: 578-584.
64. Chang GT, Jhamai M, van Weerden WM, Jenster G, Brinkmann AO (2004) The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer. Endocr Relat Cancer 11: 815-822.
65. Chang GT, Gamble SC, Jhamai M, Wait R, Bevan CL, Brinkmann AO (2007) Proteomic analysis of proteins regulated by TRPS1 transcription factor in DU145 prostate cancer cells. Biochim Biophys Acta 1774: 575-582.
66. Kaiser FJ, Moroy T, Chang GT, Horsthemke B, Ludecke HJ (2003) The RING finger protein RNF4, a co-regulator of transcription, interacts with the TRPS1 transcription factor. J Biol Chem 278: 38780-38785.
67. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.